K.V. Subramaniam is the President and CEO of Reliance Life Sciences, a research-driven organization developing business opportunities in biopharmaceuticals, pharmaceuticals, clinical research services, biofuels, regenerative medicine, molecular medicine, plant biotechnology and industrial biotechnology. Reliance Life Sciences is part of the Reliance Group of companies in India, with group revenues of US$ 35 billion in the energy and materials value chain.

K.V. Subramaniam is a Chemical Engineer from Madras University, an MBA from the Indian Institute of Management, Ahmedabad and a Chartered Financial Analyst. In a career spanning 28 years with the Reliance Group and Indian Petrochemicals Corporation Ltd., he has been responsible for several functions – from corporate business development, corporate planning, project management and economic analysis to marketing; in a range of businesses – from petrochemicals, energy, alternative energy, infrastructure, insurance, education, health care and agriculture to life sciences.

K.V. Subramaniam serves on the Board of the Institute of Chartered Financial Analysts of India, ICFAI University, GeneMedix plc UK, HN Hospital, Mumbai and the Dhirubhai Ambani International School, Mumbai.